Clinical Trial Update: Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of tiotropium and salmeterol in moderate persistent asthma patients homozygous for B16-Arg/Arg; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salmeterol (salmeterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2009-11-17